Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-25 @ 2:16 AM
NCT ID:
NCT06929260
Brief Summary:
The study aims to assess the effect of ceralasertib on the pharmacokinetics (PK) of Drug X, Drug Y and Drug Z in participants with advanced solid tumours.
Detailed Description:
This is an open-label, 3-period fixed-sequence study. The study will comprise of -
* Screening Visit (Visit 1)
* Period 1 (Visit 2)
* Period 2 (Visit 3)
* Period 3 (Visit 4)
* Follow-up Visit (Visit 5)
A wash-out period of no less than 48 hours in each period.
Study:
NCT06929260
Study Brief:
Protocol Section:
NCT06929260